Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Federal Trade Commission (FTC)

Federal Trade Commission (FTC)

Federal regulatory agency

Appears in 12 stories

Stories

The great AI deregulation

Rule Changes

Undergoing major policy shift on AI regulation

The FTC just tore up its own rulebook. On December 22, 2025, the agency voted 2-0 to reverse a year-old enforcement action against Rytr, an AI writing tool accused of enabling fake reviews.

Updated 14 minutes ago

Nvidia's $20 billion Groq deal: the AI inference land grab

New Capabilities

Scrutinizing tech consolidation; cleared Nvidia-Intel deal December 19

On Christmas Eve 2025, Nvidia paid $20 billion for Groq's assets—nearly triple the AI chip startup's $6.9 billion valuation from three months earlier. The deal brings Groq's founder Jonathan Ross, who created Google's original Tensor Processing Unit, and his breakthrough inference technology into Nvidia's fold. It's Nvidia's largest acquisition ever, nearly three times bigger than its $7 billion Mellanox purchase.

Updated 24 minutes ago

Arm Holdings faces global antitrust scrutiny over chip licensing

Rule Changes

Investigating Arm for potential monopolization

Arm Holdings sells the blueprints that power roughly 99% of the world's smartphones and a growing share of data-center chips. On May 15, Bloomberg reported that the US Federal Trade Commission has opened an antitrust investigation into how Arm hands those blueprints out.

Updated 6 hours ago

Boeing reacquires Spirit AeroSystems to confront a decade of 737 MAX safety and quality crises

Money Moves

U.S. competition regulator conditioning Boeing–Spirit merger

On December 8, 2025, Boeing completed its $4.7 billion acquisition of Spirit AeroSystems, valuing the deal at about $8.3 billion including debt. The transaction reversed a 2005 spin‑off that created the world's largest independent aerostructures supplier.

Updated 6 days ago

Trump’s unitary-executive showdown with independent agencies

Rule Changes

Test case for whether presidents may fire independent commissioners at will

In 2025, President Donald Trump challenged the 1935 Humphrey's Executor precedent by firing and removing independent agency officials before their terms expired.

Updated 6 days ago

Quantum computing crosses into commercial scale

New Capabilities

Conducting extended antitrust review of IonQ-SkyWater deal

Quantum computing has spent four decades as a physics experiment with a marketing team. On May 6, 2026, IonQ reported $50 million in quarterly revenue — up roughly 556% from a year earlier — and reaffirmed full-year guidance of $225 to $245 million, putting one of the field's leading pure-play companies on track for a quarter-billion-dollar year.

Updated May 6

Federal Trade Commission settles with Match Group over OkCupid's secret data pipeline to a facial recognition firm

Rule Changes

Plaintiff and enforcer in the settlement

In 2014, OkCupid quietly funneled nearly three million user photos — along with demographic and location data — to Clarifai, a facial recognition startup backed by OkCupid's own co-founders. Users never consented. OkCupid's privacy policy said this wouldn't happen. When a New York Times article exposed the arrangement five years later, OkCupid publicly denied it.

Updated Mar 30

Sysco bets $29 billion on Restaurant Depot to reshape food distribution

Money Moves

Expected to conduct antitrust review of the deal

Sysco, the company that delivers food to roughly one in every six restaurants in America, announced on March 30 that it would buy Jetro Restaurant Depot—the nation's largest cash-and-carry wholesaler—for $29.1 billion. The deal would combine Sysco's truck-based delivery empire with Restaurant Depot's 166 warehouse stores where independent restaurant owners walk in, load a cart, and pay cash. If approved, it would create an omnichannel food distribution giant serving more than a million customers through both delivery and self-service.

Updated Mar 30

Federal Trade Commission's expanded merger notification rules face legal challenge

Rule Changes

Defendant, appealing district court ruling

The Hart-Scott-Rodino premerger notification form went largely unchanged for 48 years. When the Federal Trade Commission tripled its compliance burden in 2024, business groups sued—and a Texas federal judge just agreed with them.

Updated Feb 18

US merger notification thresholds rise amid regulatory turbulence

Rule Changes

Primary merger review authority

The United States raised the minimum deal size requiring federal antitrust review to $133.9 million on February 15, 2026—up from $126.4 million the previous year. Companies planning mergers or acquisitions above this threshold must now file premerger notifications with the Federal Trade Commission (FTC) and Department of Justice (DOJ) and wait for government clearance before closing their deals.

Updated Feb 16

The battle to break insulin's price stranglehold

Rule Changes

Actively litigating against pharmacy benefit managers

On January 1, 2026, two unprecedented insulin programs launched simultaneously: nonprofit Civica Rx began distributing insulin glargine pens for $55 per box, while California became the first state to sell its own CalRx-branded insulin at the same price point—both undercutting branded products by up to 90%. The coordinated launches mark the first major breach in a pricing fortress built by three pharmaceutical giants who control 90% of the U.S. insulin market. Unlike existing insulin, these products require no insurance forms, no rebates, no hidden markups. Just one transparent price available to anyone.

Updated Feb 10

Kimberly-Clark's acquisition of Kenvue

Money Moves

Reviewing transaction

Johnson & Johnson spun off its consumer health division as Kenvue in May 2023, creating the world's largest pure-play consumer health company. Less than three years later, shareholders of both Kimberly-Clark and Kenvue have overwhelmingly approved a $48.7 billion acquisition that will absorb Kenvue into the Kleenex and Huggies maker—with 96% of Kimberly-Clark shares and 99% of Kenvue shares voting in favor. On January 30, 2026, The Lancet published a comprehensive study finding no evidence linking acetaminophen use during pregnancy to autism, directly contradicting concerns raised by the Trump administration that had sent Kenvue's stock tumbling in late 2025.

Updated Feb 5